Homebout REDIPartnershipActivitiesContact Us

Mission
Governing Board
bullet Administration
Location
News
   

  

Regional Emerging Disease Intervention (REDI) Centre
01 Jun 2004

  

Ag Health Minister Khaw Boon Wan officially opened the REDI Centre on 24 May 2004. The centre is a joint US-Singapore collaboration to promote cooperation in tackling emerging infectious diseases, whether naturally occurring or man-made.

The REDI Centre will facilitate the exchange of information and expertise on surveillance; prevention and control of, and research on, communicable and non-communicable diseases; and on bioterrorism concerns.

Read Ag Minister Khaw's opening address.

A Memorandum Of Understanding (MOU) was signed jointly between US Ambassador Mr Franklyn L. Lavin and Singapore's Acting Health Minister Khaw Boon Wan to establish a joint facility known as the Regional Emerging Disease Intervention (REDI) Centre on Friday, 17 Oct 2003.

Recognizing the importance of disease prevention and health to regional economic growth, and understanding that modern globalised movement of people increases the risk of rapid dissemination of infectious disease, the United States and Singapore have come together to respond to these threats through the establishment of a joint facility, the Regional Emerging Disease Intervention (REDI) Centre.

Focusing on naturally-occurring emerging diseases, such as SARS, and health security threats, including bio-terrorism concerns, the REDI Centre will:

Extend the perimeter of defense for emerging infectious diseases and health security threats.
   
Widen the international network for research in emerging infectious diseases.
   
Translate the findings of research into improved public health.

Efforts will feed into the existing surveillance efforts coordinated by the World Health Organization and will build upon the Initiative on Strengthening Health Security, announced at the APEC Leaders Meeting, in Bangkok.

The REDI Centre will enhance our shared ability to detect, monitor, and respond to emerging infectious diseases and bioterrorism threats in the Asia-Pacific region by:

Providing a base for training of public health officials, researchers, clinicians, and others health professionals. Emphasis will be on surveillance and rapid response to emerging infectious diseases and health security threats, as well as clinical research, laboratory techniques and safety, and regulatory practices.
   
Acting as a catalyst for regional collaboration on research related to infectious diseases of particular relevance to the Asia-Pacific region, including SARS, influenza, dengue, West Nile fever and other emerging and re-emerging infectious diseases.
   
Facilitating the development of new vaccines, drugs and diagnostic tests that will allow governments to detect, treat and prevent these new threats.
   
Developing the ability of Singapore to be a resource for economies in the Asia-Pacific region as they respond to new health threats, whether naturally-occurring diseases or man-made bioterrorism incidents.

Research projects for immediate implementation include work on SARS-specific vaccines and collaboration on pandemic influenza surveillance, in anticipation of future outbreaks of these diseases that could disrupt the economies of the entire Asia-Pacific region.

The REDI Centre will be open to participation by other Asia-Pacific economies.

^ top